The Center provides global testing, education and training for the pharmaceutical, medical device and biotechnology industries and will help clients gain expertise and reduce costs in the product development lifecycle

ANN ARBOR, Mich. and BRISTOL, Conn. – NSF International, a global public health organization, has established the NSF International Center of Excellence for Pharmaceutical Development at its Bristol, Conn. laboratory. As an NSF International Center of Excellence, the laboratory will provide its scientific and technical expertise and expand its robust analytical testing capabilities, education and training to more clients through its laboratories in Germany, China, Peru and Brazil.

The NSF International Center of Excellence for Pharmaceutical Development conducts testing and evaluation across the entire product lifecycle for the pharmaceutical, medical device and biotechnology industries. The Center’s expertise, which reaches a global network of laboratories, includes pre-clinical and clinical development programs, unique method development and validation capabilities, and extractable and leachable studies for pharmaceutical packaging, combination medical devices and single-use processing equipment.

Clients in Germany, China, Peru and Brazil will have access to the expert toxicology risk assessment services in support of product development and regulatory filings. They can utilize the Center’s services to evaluate challenging products, including combination pharmaceutical/medical devices such as drug-eluting stents and metered dose inhalers. These capabilities provide significant value by reducing the need to consult multiple laboratories to achieve confidence in test results, saving time and expense in the product development sequence.

Leading the global expansion will be James Scull, Ph.D., Vice President of Pharmaceutical Development in NSF International’s Health Sciences Division. Dr. Scull will leverage his more than 30 years of experience to lead the strategic development, growth and expansion for pharmaceutical and medical device testing throughout NSF International’s worldwide network of laboratories working closely with clients. Assisting Dr. Scull will be Kurt Moyer, Ph.D., General Manager of NSF Health Sciences, and Kevin Webb, Director of Operations of NSF Health Sciences, both based at the Bristol laboratory. Dr. Moyer will lead the Center while assisting in the growth and expansion of the laboratory network while Mr. Webb will ensure laboratory operations keep pace with its new role in supporting global testing services.

“We recognize that our clients need to save costs throughout the product development lifecycle and by combining our scientific and technical expertise into the NSF International Center of Excellence for Pharmaceutical Development, we can provide access to our worldwide network of laboratories with more testing, education and training capabilities in a variety of geographic locations depending upon their need,” said Dr. Scull, Vice President of Pharmaceutical Development for NSF International. “These new services will allow NSF International to deliver scientific and technical expertise to help our clients bring safer products to market.”

Editor’s Note: For media interested in more information or to schedule an interview with an NSF Health Sciences expert, please contact or call +1 734 214 6242.

About NSF International: NSF International is a global independent organization based in Ann Arbor, Mich., that writes standards, and tests and certifies products for the water, food, health sciences and consumer goods industries to minimize adverse health effects and protect the environment. Operating in more than 165 countries, NSF is accredited by the American National Standards Institute (ANSI) and is a Pan American Health Organization/World Health Organization Collaborating Center on Food Safety, Water Quality and Indoor Environment.

NSF International’s Health Sciences Division offers training and education, consulting, auditing, GMP and GLP testing, DNA testing, certification, R&D and regulatory guidance and corporate compliance for the pharmaceutical, medical device, dietary supplement and bottled water/beverage industries throughout the product lifecycle. NSF International wrote the only accredited American National Standard (NSF/ANSI 173) that verifies the health and safety of dietary supplements and also tests and certifies products to this standard.